Protagonist Therapeutics: TD Cowen raises target price to $160 from $155
PTGX•TD Cowen raised its target price for Protagonist Therapeutics to $160 from $155.
Related News
DNB proposes cancellation of up to 7,131,291 repurchased shares at next AGM
DNB•
Australia's CSL names GSK exec Deborah Waterhouse as next CEO
CSL•
RLI Corp: KBW raises target price to $74 from $69
RLI•
JPMorgan raises MSCI target price to $710 from $685
MSCI•
GM: Morgan Stanley cuts target price to $95 from $101
GM•